![](/img/cover-not-exists.png)
Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?
Kanemura, Hiroaki, Takeda, Masayuki, Nakagawa, KazuhikoVolume:
9
Journal:
Translational Lung Cancer Research
DOI:
10.21037/tlcr-20-707
Date:
August, 2020
File:
PDF, 216 KB
2020